|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 239/48 | (2006.01) |
| (11) | Number of the document | 1386917 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03025535.0 |
| Date of filing the European patent application | 1999-12-02 | |
| (97) | Date of publication of the European application | 2004-02-04 |
| (45) | Date of publication and mention of the grant of the patent | 2011-06-22 |
| (46) | Date of publication of the claims translation | 2011-09-26 |
| (30) | Number | Date | Country code |
| 9804211 | 1998-12-04 | SE | |
| 9901271 | 1999-04-09 | SE |
| (72) |
Hardern, David, GB
Ingall, Anthony, GB
Springthorpe, Brian, GB
Willis, Paul, GB
Guile, Simon, GB
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Tarpiniai junginiai tam tikrų triazolpirimidinų kaip P2T antagonistų gamybai |
| Intermediates for the preparation of certain triazolopyrimidines as P2T antagonists |
| Payment date | Validity (years) | Amount | |
| 2015-11-23 | 17 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2016-12-02 |